Evidence map›Paper›PMID 42841232›Full record

ArticleNucleic acids research2026

A dynamically frustrated allosteric checkpoint consistent with conformational proofreading in CRISPR-Cas9.

Jianxiang Huang, Jiacheng Wei, Huazhang Chen, Xin Qiao, Ning Liu, Shaoyong Lu

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianxiang HuangArtificial Intelligence Clinical Research Center for Drug Discovery, Shanghai Key Laboratory of Flexible Medical Robotics, Institute of Medical Robotics, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
Jiacheng WeiArtificial Intelligence Clinical Research Center for Drug Discovery, Shanghai Key Laboratory of Flexible Medical Robotics, Institute of Medical Robotics, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
Huazhang ChenDepartment of Pharmaceutical and Artificial-Intelligence Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Xin QiaoDepartment of Pharmaceutical and Artificial-Intelligence Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Ning LiuKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Peptide & Protein Drug Research Center, School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Shaoyong LuArtificial Intelligence Clinical Research Center for Drug Discovery, Shanghai Key Laboratory of Flexible Medical Robotics, Institute of Medical Robotics, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.ORCID 0000-0002-1334-6292

Funding

Ministry of Science and Technology of the People's Republic of ChinaNoncommunicable Chronic Diseases-National Science and Technology Major Project of China 2024ZD0531200Program for Innovative Research Team of High-Level Local Universities in ShanghaiShanghai Municipal Education Commission
6 · The paper itself

Abstract

CRISPR-Cas9 DNA cleavage requires R-loop extension to activate the histidine-asparagine-histidine (HNH) nuclease domain, yet how heteroduplex maturation gates catalytic commitment remains unclear. Using extensive molecular dynamics simulations across seven experimentally trapped heteroduplex states (6-18 nt), we define a three-stage activation pathway: unlocking, preorganization, and precatalytic gating. At the 18-nt checkpoint, HNH and REC2 regain mobility but do not adopt a fully cleavage-competent orientation; this dynamically frustrated metastate is consistent with a conformational-proofreading model. Here, dynamic frustration is used operationally to describe renewed mobility and weakened directional coupling without commitment to the cleavage-competent state, rather than a formal energetic frustration calculation. Two sensors, Y450 at the sgRNA: DNA hybrid interface and K1200 in the PI domain, respond to distinct maturation milestones, encoding heteroduplex length into domain-specific conformational outputs. Integrating these insights with two deep-learning analyses and deep mutational scanning recovers known high-fidelity positions and prioritizes three unannotated residues for testing. In a cellular cleavage reporter assay, R1210D reproduces the attenuated low-completion phenotype of eSpCas9, identifying it as a candidate for direct specificity testing, while destabilizing L1-linker substitutions increase cleavage efficiency. These results connect atomic-level dynamics to experimentally testable, structure-mechanism-informed engineering hypotheses; direct matched-versus mismatched validation is required to establish effects on discrimination fidelity.

Indexed as

CRISPR-Associated Protein 9CRISPR-Cas SystemsAllosteric RegulationDNADNA CleavageMolecular Dynamics SimulationRNA, Guide, CRISPR-Cas SystemsCRISPR-Associated Protein 9DNARNA, Guide, CRISPR-Cas Systems

Identifiers

PMID42841232
PMCPMC13643172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.